chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIP SWELLING (her lower lip kind of swelled and she could feel it,), LIP SWELLING (the feeling in her lips last a few days), HYPOAESTHESIA (still feeling a stiffness inside her face), HYPOAESTHESIA ORAL (stiffness in her lower lip) and HYPOAESTHESIA (feel numbness on her face on the right side) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), MULTIVITAMIN [VITAMINS NOS] and CALCIUM, COLECALCIFEROL (CALCIUM PLUS D3) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced LIP SWELLING (her lower lip kind of swelled and she could feel it,). On 15-Apr-2021, the patient experienced HYPOAESTHESIA (still feeling a stiffness inside her face) and HYPOAESTHESIA (feel numbness on her face on the right side). On 04-May-2021, the patient experienced LIP SWELLING (the feeling in her lips last a few days) and HYPOAESTHESIA ORAL (stiffness in her lower lip). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency and FAMOTIDINE (PEPCID AC) at an unspecified dose and frequency. At the time of the report, LIP SWELLING (her lower lip kind of swelled and she could feel it,), LIP SWELLING (the feeling in her lips last a few days), HYPOAESTHESIA (still feeling a stiffness inside her face), HYPOAESTHESIA ORAL (stiffness in her lower lip) and HYPOAESTHESIA (feel numbness on her face on the right side) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal limits. On an unknown date, Computerised tomogram: normal (normal) look at blood vessels. normal limits. On an unknown date, Electrocardiogram: normal (normal) normal limits. On an unknown date, Neurological examination: normal (normal) normal limits.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
he had numbness in his face; Migraine was so bad/Migraine was returning after 1st dose Covid vaccine; Migraine was so bad/Migraine was returning after 1st dose Covid vaccine; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration at the age of 19 years old on 01Jul2021 (Batch/Lot Number: EW0180) as dose 2, single for covid-19 immunisation. Medical history included diabetes mellitus, allergy and migraine. Concomitant medication(s) included topiramate (TOPAMAC) taken for an unspecified indication, start and stop date were not reported. The patient received the first dose of BNT162B2 (lot number: EW0177) on 10Jun2021 for covid-19 immunisation and experienced migraine, headache and numbness in the face. On an unspecified date, the patient experienced migraine. It was stated that migraine was returning after first dose of Covid vaccine that it was so bad he had numbness in his face. The patient received Tylenol and Ibuprofen but was not helping. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Roughly 10-13 minutes after injection patient reports numbness and tingling in arm of administration.  Also complains of sharp chest pain.  VS-152/92, 92, 24, 99% on RA.  Advised to go to ER for further evaluation.  Spouse came and picked patient up and took to the ER she did not want to go via ambulance.
99°F temperature; allergic gastroesophageal; an "interval" headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic gastroesophageal), HEADACHE (an "interval" headache) and PYREXIA (99°F temperature) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, INSULIN, Allergies Medication and Gastritis Medication for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced HYPERSENSITIVITY (allergic gastroesophageal) and HEADACHE (an "interval" headache). On an unknown date, the patient experienced PYREXIA (99°F temperature). At the time of the report, HYPERSENSITIVITY (allergic gastroesophageal), HEADACHE (an "interval" headache) and PYREXIA (99°F temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.   Reporter did not allow further contact
Day after vaccine parents noticed redness/swelling at the site. Parents outlined area, gave Benadryl as per conversation with on-call physician. Parents concerned with redness and swelling so provider saw them on 5/2/21, and started Cephalexin 250mg/ml; take 7.5ml BID x 10 days to cover forcellulitis.
EXPIRED PRODUCT ADMINISTERED; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 22-SEP-2021, the patient experienced expired product administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired product administered was not reported. This report was non-serious. This case, from the same reporter is linked to 20210943895.
Violent chills and shaking followed by fever of 102. This lasted until about 5 AM.
Lymph nodes in neck swollen on left side; Brightness in vision; soreness in arm; Headache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIPLOPIA (Brightness in vision), PAIN IN EXTREMITY (soreness in arm), HEADACHE (Headache), LYMPHADENOPATHY (Lymph nodes in neck swollen on left side) and CHILLS (Chills) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol high.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). On 15-Feb-2021, the patient experienced DIPLOPIA (Brightness in vision). On 16-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes in neck swollen on left side). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE (COUGH SYRUP DEXTROMETHORPHAN) at an unspecified dose and frequency. At the time of the report, DIPLOPIA (Brightness in vision), PAIN IN EXTREMITY (soreness in arm), HEADACHE (Headache), LYMPHADENOPATHY (Lymph nodes in neck swollen on left side), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were cholesterol meds were used for
About 7-10 days after vaccine 1/15/21, experienced soreness in left forearm, weak grip, significant swelling in front of neck Thyroid area. Met for an already planned health visit 1/29/21 and she was immediately concerned about the apparent swelling "goiter" and drew labs and ordered an ultrasound of the Thyroid which was done on 2/1/21 at imaging center results not showing any concerns with blood or Thyroid. After doctor visit with PCP, ordered 2nd Ultrasound  5/7/21 and labs, findings also no concerns. Friday 5/7/21 met with orthopedic MD who ordered physical therapy for "tendonitis" in left arm, have been doing physical therapy and is helping.
Swelling in right thigh extending down to knee but not involving hip of knee, warmth, minimally erythematous. No palable masses, Fluctence; No pain with exam, no inguinal nodes, otherwise normal exam. DX1) Large local reaction 2) Cellulitis, TX 1)Augmentin ?  kg/day x 10 days 2) Ice 3) ?
Pt recv vax on 2/2/99; on same day pt exp edema of LA w/ redness, warmth & itch; tx=calamine lotion
PT GIVE ZOSTAVAX ON 9/8/09, VISITED DR WITH RASH ON 9/11/09, CONFIRMED SHINGLES ON 9/14/09.
Client had called to report redness of left deltoid area no for child. States child ate well and played normally. Mother stated she took child to the ED at 11. Physical
Felt great until day 3 when my right arm became extremely sore and red. I used Ibuprofen and it was better the next day.
07/18/2022 that morning she woke up with a crusty, swollen and puffy right eye. We contacted her Pediatric nurse and was given a prescription for an antibiotic. The antibiotic has cleared it all up.
Patient had erythema at area of injection and swelling. One week later patient denies any pain or itching. Patient uses cool pack as needed.
It was reported by the patient that he an adult male patient, received a Fluzone SV 2001/2002 vaccination administered in 11/01. Approximately one week later the patient developed a rough rash inside his mouth and lower lip, patient also developed urethritis--these symptoms are currently unresolved.
Pt developed a 7 x 9.5 cm area of erythema, induration, warmth and swelling on 8/29/01.
15 minutes post vaccine patient reported no adverse reaction. patient came back to pharmacy ~24 hours later with small bumps/hives and flushing on arm that received the bivalent vaccine. States her arm started itching ~ 4 hours after she received the vaccine on 9/24/22. She left the pharmacy with zyrtec and hydrocortisone and was advised to follow up with pcp.
Told by 3rd party that client stated above is in hospital for Idiopathic Thrombocytopenia Purpura. Consult with Immunization Division to verify need for VAERS report.
Patient received his shot during an immunization clinic at about 08:40am on 03/29/21 and while waiting at the observation area he passed out and fell off his seat. Another patient who observed him fall said he hit his head on the floor. By the time the pharmacist got to the patient he was alert and requested to lay on the floor as this would help him recover better. EMS was called to help the patient further patient .  Patient informed the pharmacist that this was a common occurrence when he receives shots or gets blood drawn.
Loss of Smell; Loss of Taste; Sinus Infection; Headache; Positive COVID-19 test; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID-19 test), ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032LZOA and 026L2VA) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Positive COVID-19 test). On an unknown date, the patient experienced ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, COVID-19 (Positive COVID-19 test), ANOSMIA (Loss of Smell), AGEUSIA (Loss of Taste), HEADACHE (Headache) and SINUSITIS (Sinus Infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jul-2021, SARS-CoV-2 test: positive (Positive) Covid-19. On 06-Jul-2021, SARS-CoV-2 test: not known (Inconclusive) Currently waiting the results.         Concomitant medications were not reported.
soreness spread to wrist and across back to other arm; "muscle in leg is real sore"; soreness spread to wrist and across back to other arm; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), MYALGIA ("muscle in leg is real sore"), ARTHRALGIA (soreness spread to wrist and across back to other arm) and BACK PAIN (soreness spread to wrist and across back to other arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID (CHEMO C) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and ARTHRALGIA (soreness spread to wrist and across back to other arm). On 19-Apr-2021, the patient experienced MYALGIA ("muscle in leg is real sore"). On an unknown date, the patient experienced BACK PAIN (soreness spread to wrist and across back to other arm). At the time of the report, PAIN IN EXTREMITY (sore arm), MYALGIA ("muscle in leg is real sore"), ARTHRALGIA (soreness spread to wrist and across back to other arm) and BACK PAIN (soreness spread to wrist and across back to other arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Hydrocodone 7.5mg as treatment medication for other pains.
Deceased (11.14.21);  Hospitalized (11.5.21);  COVID-19 positive (11.5.21);  fully vaccinated Admission Date: 11/5/2021 Date of Death: 11/14/21 Time of Death:  9:15 AM Preliminary Cause of Death: COVID-19 virus infection HOSPITAL COURSE: Admission H and P :  Patient is a 86 y.o. male who presents today with weakness and diarrhea per ER notes. He states "the COvid is the reason they gave me this room here." Patient denies falling or having increased confusion today but per Er notes patient had increased confusion. Patient struggles to tell me why he is in the hospital. He denies SOB but is having a cough and it is occasionally productive. Patients denies chest or abdominal pain and denies having diarrhea though does not that he is having some nausea. He notes that he has chills all the time but denies fever. He has some mild congestion and runny nose. He has his sense of taste and smell but does not eat much lately. He denies feeling more weak or fatigued than his baseline and is not having body aches. He thinks that his son had COVID "I think he is getting tested now." Patient states "I had a bad infection in my foot and had my toes amputated last month and had vascular surgery." he notes that his foot is healing well and he was seen by vascular surgery, he last saw them on 11/2.  Per ER notes and report patient had increased confusion today when home health was over doing therapy. They were concerned about him being more weak and not participating like normal. He was also having increased confusion so they recommended that he come into the ER. IN the ER patient was noted to be positive for COVID. CXR showing Patchy opacity in the left mid lung zone may represent infection but imaging follow-up to resolution is recommended. He had head CT that was negative for acute findings. KUB of abdomen was completed showing no acute findings but shows AAA with bilateral iliac stent grafts in place. Patient will be admitted for weakness/confusion and COVID.               Following admission was placed on decadron rx , did not qualify for other treatment rx . oxygenation remained stable . On presentation inr was supra tx and was held and dosed by our pharmacy dosing service . Identified sacral pressure ulcer present on admit was evaluated by our wound care team with dressing changes and care directed by them. He remained generally weak Likely 2/2 COVID and recent infection with toe amputation on underlying mild dementia . Through out stay was confusion and delirium waxed and waned and did escalate requiring both physical and chemical restraints . Discussions with family with    Plans for signing on with north ottawa Hospice when bed available . Goals of care discussed with over all quality of life declining with underlying  Dementia . Hospice care was consulted in the hospital and patient was made GIP Hospice . He was placed on comfort care orders with analgesics , anxiolytics  And passed peacefully in the hospital
she is a little bit handicapped; after received the vaccine (PNEUMOVAX), she had soreness in her arm; after she received the FLU shot, she had soreness in her arm; still hurts if she bumps it; This spontaneous report was received from an 86-year-old female patient reporting on herself. The patient's current conditions included glaucoma. The patient had not known drug reactions/allergies.  The patient's medical history included 3 surgeries, physiotherapy, shingles, chickenpox, fall and hip fracture.  Concomitant therapies included atorvastatin, lisinopril, amlodipine besilate and eye drops for glaucoma.  On an unknown date, reported as "few years ago", the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), one dose, intramuscularly, for pneumonia immunization (dose, site of administration, lot number and expiration date were not reported).   After she received the vaccine, she had soreness in her arm (pain in extremity).  She did not contact her healthcare provider because the soreness was not bad enough and she did not take any medication for treatment of her symptoms.    On 09-NOV-2021, the patient received her annual influenza vaccine (FLU), shot and she had soreness in her arm after vaccination (pain in extremity).  The soreness was better but still hurt if she "bump it" (pain).  The patient stated she recently received her covid-19 vaccine(COVID-19 VACCINE) booster shot.  Also she had received the mumps vaccine (MUMPS VACCINE), diphtheria vaccine (DIPHTHERIA VACCINE), the zoster vaccine live and the shingles vaccine (manufacturer unknown).  The patient stated she was "a little bit handicapped" (disability).  The outcome of disability and pain in extremity was unknown.    The reporter did not assess the causal relationship between suspect therapies with and the events.  Upon internal review disability was determined medically significant.
Patient developed an ocular migraine 3 days after vaccination. She has no history of migraines. She had a yellowish haze in vision of her left eye. She treated with ibuprofen and migraine resolved in 3 days.
chest congestion; sore arm; A spontaneous report  was received from a consumer concerning a 67- year old-male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced chest congestion and vaccination site pain.  The patient's medical history was not provided.No relevant concomitant medications were reported.   On 30-Jan-2021,prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (lot/batch 007M20A) on left arm for prophylaxis of COVID-19 infection.  On an unknown date,the patient experienced chest congestion and sore arm. No laboratory data was provided.Treatment information was not provided.   Action taken with mRNA-1273 in response to the events  was unknown.   The outcome of the events chest congestion and pain in arm  was considered as unknown at the time of the report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
2MAR94 t100.3, diaper rahs asymptomatic; 5MAR94 mom noted lt eye unable to close & rt lower lip drooping to the side; seen by MD:
Felt weak; Dry throat; States she has noticed she has been burping a lot and coughing harder.; States she has noticed she has been burping a lot and coughing harder.; She has a dry cough and when she coughs hard she gags until almost vomiting/ she has had some coughing where she coughs until she feels like she has to throw up; she has been having shortness of breath that started when she got the first dose of the Pfizer COVID vaccine on 27Jan2021; Chills; she just felt tired was all; pain at the injection site in her right arm so she took Tylenol that morning; This is a spontaneous report from a contactable nurse (patient). A 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9265) dose 1 via intramuscular route of administration in Arm Right on 27Jan2021 at 13:30(at the age of 80 years old) as single for COVID-19 immunisation. Medical history was none. There were no concomitant medications. Patient had no other vaccines on the same day as the COVID vaccine. The patient experienced as, she has been having shortness of breath that started when she got the first dose of the pfizer covid vaccine, chills, she just felt tired was all, pain at the injection site in her right arm so she took tylenol that morning on 27Jan2021, felt weak on 07Feb2021, she has noticed she has been burping a lot and coughing harder, she has a dry cough and when she coughs hard she gags until almost vomiting/ she has had some coughing where she coughs until she feels like she has to throw up, and dry throat on an unspecified date on Feb2021. Therapeutic measures were taken as a result of she just felt tired was all and pain at the injection site in her right arm so she took tylenol that morning. The patient underwent lab tests and procedures which included weight: 145-147 on an unspecified date. Therapeutic measures were taken as a result of she just felt tired was all and pain at the injection site in her right arm so she took tylenol that morning. Outcome of the event shortness of breath and chills were recovered and unknown for rest events.  Information about batch/lot number has been requested.  Follow-up attempts are completed. No further information is expected.
syringe malfunction and they had a loss of dose on the person's skin; syringe malfunction and they had a loss of dose on the person's skin; This is a spontaneous report from a contactable Pharmacist. This Pharmacist reported for a consumer (patient) that: A 47-years-old female patient started to receive first dose of bnt162b2 (Pfizer-BioNtech Covid-19 Vaccine, solution for injection, Batch/Lot Number: EW0178; Expiration Date: Aug2021) via an unspecified route of administration on 24May2021 as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 24May2021, patient was given a shot of the COVID vaccine first dose and there may have been a syringe malfunction and they had a loss of dose on the person skin. The reporter considers the events as non-serious. The outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Patient report tingling in both legs, dehydrated, chills, dark spots all over body w/ burning sensation, and shaking